{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:45:53Z","timestamp":1787636753730,"version":"build-2736575974"},"reference-count":42,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"crossref","award":["CES-2023-008"],"award-info":[{"award-number":["CES-2023-008"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001637","name":"Trinity College Dublin","doi-asserted-by":"publisher","award":["1252 Scholarship"],"award-info":[{"award-number":["1252 Scholarship"]}],"id":[{"id":"10.13039\/501100001637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,10,17]]},"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The objective of this study is to identify the top 10 research priorities on reducing and stopping psychiatric medication that reflect the perspectives and unmet needs of three key stakeholder groups (people with lived experience, family members\/carers\/supporters and healthcare professionals).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A priority-setting partnership was conducted using the James Lind Alliance\u2019s seven-step process. This involved (1) creating an international Steering Group of key stakeholder representatives and (2) identifying potential partners; (3) gathering stakeholders\u2019 uncertainties about reducing and stopping psychiatric medication using an online survey and summarising the survey responses; (4) checking the summary questions against existing evidence and verifying uncertainties; (5) shortlisting the questions using a second online survey; (6) determining the top 10 research questions through a prioritisation workshop; and (7) disseminating the results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 3635 questions were collected in the initial survey from 884 respondents of which 32 questions were verified as uncertainties. These questions were then ranked in a second online survey by 526 respondents and the findings discussed in a final prioritisation workshop by 30 participants to produce the final top 10 list of research questions. These questions cover a range of areas including the most effective ways of safely reducing\/stopping psychiatric medication and providing support to individuals undergoing the discontinuation process, as well as the best ways to educate healthcare professionals on this topic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The top 10 list of research priorities was produced through extensive engagement with key stakeholders and highlights important uncertainties and gaps in the existing evidence base that need to be addressed by future research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-088266","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T18:40:30Z","timestamp":1730832030000},"page":"e088266","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Identifying priorities for future research on reducing and stopping psychiatric medication: results of a James Lind Alliance priority-setting partnership"],"prefix":"10.1136","volume":"14","author":[{"given":"Miriam","family":"Boland","sequence":"first","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Higgins","sequence":"additional","affiliation":[{"name":"School of Nursing and Midwifery, Trinity College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Beecher","sequence":"additional","affiliation":[{"name":"Evidence Synthesis Ireland and Cochrane Ireland, University of Galway, Galway, Ireland"},{"name":"School of Nursing and Midwifery, University of Galway, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pat","family":"Bracken","sequence":"additional","affiliation":[{"name":"Independent Consultant Psychiatrist, West Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Burn","sequence":"additional","affiliation":[{"name":"Leeds and York Partnership NHS Foundation Trust, Leeds, UK"},{"name":"Past President, Royal College of Psychiatrists, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Cody","sequence":"additional","affiliation":[{"name":"Health Research Board, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Framer","sequence":"additional","affiliation":[{"name":"SurvivingAntidepressants.org, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toto","family":"Gronlund","sequence":"additional","affiliation":[{"name":"James Lind Alliance, NIHR, Llanrwst, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1318-2029","authenticated-orcid":false,"given":"Mark","family":"Horowitz","sequence":"additional","affiliation":[{"name":"Goodmayes Hospital, North East London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"Huff","sequence":"additional","affiliation":[{"name":"Benzodiazepine Information Coalition, Utah, Utah, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Jayacodi","sequence":"additional","affiliation":[{"name":"Lived Experience Public Contributor, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7507-2680","authenticated-orcid":false,"given":"Dolores","family":"Keating","sequence":"additional","affiliation":[{"name":"Pharmacy Department, St. John of God Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kessler","sequence":"additional","affiliation":[{"name":"Centre for Academic Mental Health, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa","family":"Konradsson-Geuken","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden"},{"name":"European Federation of Associations of Families with Mental Illness, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Lamberson","sequence":"additional","affiliation":[{"name":"Benzodiazepine Information Coalition, Utah, Utah, USA"},{"name":"International Institute for Psychiatric Drug Withdrawal, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Montagu","sequence":"additional","affiliation":[{"name":"Council for Evidence-based Psychiatry, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Smith","sequence":"additional","affiliation":[{"name":"Public Partner, Brighton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8778-0112","authenticated-orcid":false,"given":"Cathal","family":"Cadogan","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"2025120618540698000_14.11.e088266.1","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S2215-0366(21)00292-3","article-title":"Psychotropic medicine consumption in 65 countries and regions, 2008-19: a longitudinal study","volume":"8","author":"Brauer","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"2025120618540698000_14.11.e088266.2","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1136\/bmj.p2730","article-title":"Politicians, experts, and patient representatives call for the UK government to reverse the rate of antidepressant prescribing","volume":"383","author":"Davies","year":"2023","journal-title":"BMJ"},{"key":"2025120618540698000_14.11.e088266.3","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.111.104257"},{"key":"2025120618540698000_14.11.e088266.4","doi-asserted-by":"crossref","DOI":"10.1177\/2054270418758570","article-title":"A quantitative analysis of antipsychotic prescribing trends for the treatment of schizophrenia in England and Wales","volume":"9","author":"Roberts","year":"2018","journal-title":"JRSM Open"},{"key":"2025120618540698000_14.11.e088266.5","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13570"},{"key":"2025120618540698000_14.11.e088266.6","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h2435","article-title":"Does long term use of psychiatric drugs cause more harm than good?","volume":"350","author":"G\u00f8tzsche","year":"2015","journal-title":"BMJ"},{"key":"2025120618540698000_14.11.e088266.7","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-022-03822-5","article-title":"An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disorders","volume":"22","author":"Crellin","year":"2022","journal-title":"BMC Psychiatry"},{"key":"2025120618540698000_14.11.e088266.8","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/inm.12894","article-title":"Deciding to discontinue prescribed psychotropic medication: A qualitative study of service users\u2019 experiences","volume":"30","author":"Watts","year":"2021","journal-title":"Int J Mental Health Nurs"},{"key":"2025120618540698000_14.11.e088266.9","doi-asserted-by":"publisher","DOI":"10.1080\/09638237.2021.1922644."},{"key":"2025120618540698000_14.11.e088266.10","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/schbul\/sbab017","article-title":"A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse","volume":"47","author":"Horowitz","year":"2021","journal-title":"Schizophr Bull"},{"key":"2025120618540698000_14.11.e088266.11","doi-asserted-by":"crossref","DOI":"10.1177\/2045125321991274","article-title":"What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications","volume":"11","author":"Framer","year":"2021","journal-title":"Ther Adv Psychopharmacol"},{"key":"2025120618540698000_14.11.e088266.12","doi-asserted-by":"crossref","DOI":"10.1177\/20451253211032051","article-title":"Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA","volume":"11","author":"Hengartner","year":"2021","journal-title":"Ther Adv Psychopharmacol"},{"key":"2025120618540698000_14.11.e088266.13","doi-asserted-by":"crossref","DOI":"10.1177\/20451253211067656","article-title":"Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review","volume":"12","author":"S\u00f8rensen","year":"2022","journal-title":"Ther Adv Psychopharmacol"},{"key":"2025120618540698000_14.11.e088266.14","doi-asserted-by":"crossref","unstructured":"Fricker M . Epistemic injustice: power and the ethics of knowing. Oxford, UK Oxford University Press; 2007.","DOI":"10.1093\/acprof:oso\/9780198237907.001.0001"},{"key":"2025120618540698000_14.11.e088266.15","doi-asserted-by":"crossref","unstructured":"Miller R , Pavlo A . From deinstitutionalization to deprescribing and beyond. In: Davidson CA , Stacy M , eds. Recovering the us mental healthcare system: The past, present, and future of psychosocial interventions for psychosis. Cambridge, UK: Cambridge University Press, 2022.","DOI":"10.1017\/9781108951760.011"},{"key":"2025120618540698000_14.11.e088266.16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/09638230802453682","article-title":"Service user produced knowledge","volume":"17","author":"Rose","year":"2008","journal-title":"J Ment Health"},{"key":"2025120618540698000_14.11.e088266.17","unstructured":"Mental health, human rights, and legislation: guidance and practice, Licence:\u00a0CCBY-NC-SA 3.0 IGO. Geneva World Health Organization and the United Nations (represented by the Office of the United Nations High Commissioner for Human Rights); 2023. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240080737 [accessed 13 Feb 2024]"},{"key":"2025120618540698000_14.11.e088266.18","unstructured":"James Lind Alliance . The James Lind Alliance Guidebook. Version 10. Southampton, United Kingdom, 2021. Available: https:\/\/www.jla.nihr.ac.uk\/jla-guidebook\/ [accessed 13 Feb 2024]."},{"key":"2025120618540698000_14.11.e088266.19","doi-asserted-by":"crossref","DOI":"10.12688\/hrbopenres.13649.1","article-title":"Priorities for future research on reducing and stopping psychiatric medicines using a James Lind Alliance priority setting partnership: The PROTECT study protocol","volume":"5","author":"Boland","year":"2022","journal-title":"HRB Open Res"},{"key":"2025120618540698000_14.11.e088266.20","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-019-0889-3","article-title":"Reporting guideline for priority setting of health research (REPRISE)","volume":"19","author":"Tong","year":"2019","journal-title":"BMC Med Res Methodol"},{"key":"2025120618540698000_14.11.e088266.21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/14780887.2014.955224","article-title":"The Utility of Template Analysis in Qualitative Psychology Research","volume":"12","author":"Brooks","year":"2015","journal-title":"Qual Res Psychol"},{"key":"2025120618540698000_14.11.e088266.22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/jiaps.JIAPS_76_18","article-title":"Formulation of Research Question - Stepwise Approach","volume":"24","author":"Ratan","year":"2019","journal-title":"J Indian Assoc Pediatr Surg"},{"key":"2025120618540698000_14.11.e088266.23","doi-asserted-by":"crossref","DOI":"10.1186\/s40900-016-0054-7","article-title":"Priority setting in research: user led mental health research","volume":"3","author":"Ghisoni","year":"2017","journal-title":"Res Involv Engagem"},{"key":"2025120618540698000_14.11.e088266.24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s44220-023-00029-9","article-title":"Lived experience involvement in research funding: taking a more systematic approach","volume":"1","author":"White","year":"2023","journal-title":"Nat Mental Health"},{"key":"2025120618540698000_14.11.e088266.25","doi-asserted-by":"publisher","DOI":"10.1177\/1355819613500665"},{"key":"2025120618540698000_14.11.e088266.26","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320932452","article-title":"How user knowledge of psychotropic drug withdrawal resulted in the development of person-specific tapering medication","volume":"10","author":"Groot","year":"2020","journal-title":"Ther Adv Psychopharmacol"},{"key":"2025120618540698000_14.11.e088266.27","unstructured":"National Institute for Health and Care Excellence . NICE guideline: medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults. 2022. Available: https:\/\/www.nice.org.uk\/guidance\/ng215 [Accessed 08 Mar 2024]."},{"key":"2025120618540698000_14.11.e088266.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2018.08.027"},{"key":"2025120618540698000_14.11.e088266.29","article-title":"Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults","volume":"4","author":"Van Leeuwen","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2025120618540698000_14.11.e088266.30","article-title":"Psychosocial interventions for benzodiazepine harmful use, abuse or dependence","volume":"2015","author":"Darker","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2025120618540698000_14.11.e088266.31","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320967183","article-title":"The \u201cpatient voice\u201d: patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition","volume":"10","author":"Guy","year":"2020","journal-title":"Ther Adv Psychopharmacol"},{"key":"2025120618540698000_14.11.e088266.32","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp21X716309"},{"key":"2025120618540698000_14.11.e088266.33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/jpm.12600","article-title":"Antipsychotic medication side effects knowledge amongst registered mental health nurses in England: A national survey","volume":"27","author":"Begum","year":"2020","journal-title":"J Psychiatr Ment Health Nurs"},{"key":"2025120618540698000_14.11.e088266.34","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320950124","article-title":"A survey of UK general practitioners about depression, antidepressants and withdrawal: implementing the 2019 Public Health England report","volume":"10","author":"Read","year":"2020","journal-title":"Ther Adv Psychopharmacol"},{"key":"2025120618540698000_14.11.e088266.35","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jpsychires.2023.03.013","article-title":"Designing withdrawal support services for antidepressant users: Patients\u2019 views on existing services and what they really need","volume":"161","author":"Read","year":"2023","journal-title":"J Psychiatr Res"},{"key":"2025120618540698000_14.11.e088266.36","doi-asserted-by":"crossref","first-page":"115303","DOI":"10.1016\/j.psychres.2023.115303","article-title":"The need for antidepressant withdrawal support services: Recommendations from 708 patients","volume":"326","author":"Read","year":"2023","journal-title":"Psychiatry Res"},{"key":"2025120618540698000_14.11.e088266.37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.addbeh.2018.08.021","article-title":"Staying on, and coming off, antidepressants: The experiences of 752 UK adults","volume":"88","author":"Read","year":"2019","journal-title":"Addict Behav"},{"key":"2025120618540698000_14.11.e088266.38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218711","article-title":"Mental health professionals\u2019 views and experiences of antipsychotic reduction and discontinuation","volume":"14","author":"Cooper","year":"2019","journal-title":"PLoS ONE"},{"key":"2025120618540698000_14.11.e088266.39","doi-asserted-by":"crossref","DOI":"10.1177\/20451253211039327","article-title":"Successful use of tapering strips for hyperbolic reduction of antidepressant dose: a cohort study","volume":"11","author":"Groot","year":"2021","journal-title":"Ther Adv Psychopharmacol"},{"key":"2025120618540698000_14.11.e088266.40","doi-asserted-by":"crossref","DOI":"10.1186\/s12961-019-0432-3","article-title":"The dark side of coproduction: do the costs outweigh the benefits for health research?","volume":"17","author":"Oliver","year":"2019","journal-title":"Health Res Policy Syst"},{"key":"2025120618540698000_14.11.e088266.41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/hex.13384","article-title":"Pragmatism as a paradigm for patient-oriented research","volume":"25","author":"Allemang","year":"2022","journal-title":"Health Expect"},{"key":"2025120618540698000_14.11.e088266.42","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw144"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-088266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T02:54:20Z","timestamp":1765076060000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-088266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,5]]},"published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1136\/bmjopen-2024-088266"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-088266","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}